Blume Capital Management’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-600	Closed	-$11K	–	222
2019 Q1	$11K	Sell	600 -600	-50%	-$11K	0.01%	180
2018 Q4	$15K	Buy	+1,200	New	+$15K	0.01%	174